EUVIMEDEUVIMED entdecken
Vergleichsstudie

Feasibility of Computed Tomography as a Gatekeeper for Invasive Angiography Before TAVR: A Pragmatic Real-World Experience

Asa Phichaphop iD, Paul Sorajja iD, Maurice Enriquez-Sarano iD, Miho Fukui iD, Atsushi Okada iD, Davide Margonato, Mohammed Abed iD, Takahiro Nishihara, Hideki Koike iD, Evan Walser-Kuntz iD, John R Lesser, Victor Y Cheng und 3 weitere

Circulation: Cardiovascular Interventions · 2025

DOI: 10.1161/circinterventions.125.015181 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Circulation: Cardiovascular Interventions, 2025. Verfasst von Asa Phichaphop und 14 weiteren Autor:innen. Beteiligte Einrichtung: Valve Science Center (A.P., P.S., M.E.-S., A.O., M.A., E.W.-K., J.R.L., V.N.B., N.H.), Minneapolis Heart Institute Foundation, MN. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Coronary Angiography, Computed Tomography Angiography, Coronary Artery Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Although pretranscatheter aortic valve replacement-computed tomography angiography (TAVR-CTA) has shown a good correlation with invasive coronary angiography (ICA) for ruling out obstructive coronary artery disease (CAD), its clinical effectiveness and safety as a gatekeeper for ICA pre-transcatheter aortic valve replacement (pre-TAVR) remain unclear. This study aims to determine whether routine TAVR-CTA, without premedication, could safely defer and guide the need for ICA pre-TAVR. METHODS: Patients who underwent TAVR evaluation with either TAVR-CTA or ICA to determine CAD between 2017 and 2022 were included. Patients with prior coronary artery bypass grafts were excluded, and the remaining patients were divided into CAD screening with TAVR-CTA or ICA groups. The primary outcome was symptom-driven revascularization at 1 year post-TAVR. RESULTS: Among 1165 patients (median age, 81 years; 46% women), 464 were in TAVR-CTA group and 701 were in the ICA group. Prevalence of CAD was similar (37% versus 41%; P =0.2). A total of 53% of patients were exempted from ICA after TAVR-CTA, given the absence of proximal obstructive CAD, whereas 17% had inconclusive TAVR-CTA interpretation, 15% desired for ICA despite CAD exclusion by TAVR-CTA, and 14% had obstructive CAD requiring further ICA. Elevated coronary artery calcium score and the presence of stents were associated with need for ICA after TAVR-CTA. TAVR-CTA revealed a per-patient sensitivity of 89%, specificity of 75%, positive predictive value of 69%, and negative predictive value of 91% for identifying obstructive CAD. Importantly, symptom-driven revascularization, acute coronary syndrome, and unplanned ICA at 1 year after TAVR were all low and not different between TAVR-CTA versus ICA (0.8% versus 1.8%, P =0.158; 1.6% versus 1.7%, P =0.846; 2.7% versus 2.8%, P =0.767; respectively). CONCLUSIONS: In comparison with routine ICA pre-TAVR, integration of TAVR-CTA in our program resulted in up to 53% of patients exempted from ICA, while maintaining patient safety. This approach could have important clinical implications to improve patient access, experience, value, and throughput.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementCoronary AngiographyComputed Tomography AngiographyCoronary Artery DiseaseAortic Valve StenosisAortic ValveHumansFemaleMaleAgedAged, 80 and overFeasibility StudiesPredictive Value of TestsTreatment OutcomeRetrospective StudiesTime FactorsRisk FactorsClinical Decision-MakingPatient SelectionRisk Assessment

Stichwörter der Autor:innen

aortic valve stenosiscomputed tomography angiographycoronary artery diseasepatient safetytranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Valve Science Center (A.P., P.S., M.E.-S., A.O., M.A., E.W.-K., J.R.L., V.N.B., N.H.), Minneapolis Heart Institute Foundation, MN.
  • Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand (A.P.).
  • Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital, MN (P.S., J.R.L., V.Y.C., V.N.B., N.H., J.L.C.).
  • Cardiovascular Imaging Research Center and Core Lab (M.F., D.M., T.N., H.K., J.L.C.), Minneapolis Heart Institute Foundation, MN.

ORCID-Profile: Asa Phichaphop, Paul Sorajja, Maurice Enriquez-Sarano, Miho Fukui, Atsushi Okada, Mohammed Abed, Hideki Koike, Evan Walser-Kuntz, Vinayak N Bapat, João L Cavalcante

Zitieren

APA

Phichaphop, A., Sorajja, P., Enriquez-Sarano, M., Fukui, M., Okada, A., Margonato, D., Abed, M., Nishihara, T., Koike, H., Walser-Kuntz, E., Lesser, J. R., Cheng, V. Y., Bapat, V. N., Hamid, N., & Cavalcante, J. L. (2025). Feasibility of Computed Tomography as a Gatekeeper for Invasive Angiography Before TAVR: A Pragmatic Real-World Experience. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.015181

Vancouver

Phichaphop A, Sorajja P, Enriquez-Sarano M, Fukui M, Okada A, Margonato D, et al. Feasibility of Computed Tomography as a Gatekeeper for Invasive Angiography Before TAVR: A Pragmatic Real-World Experience. Circulation: Cardiovascular Interventions. 2025. doi:10.1161/circinterventions.125.015181

BibTeX
@article{Phichaphop2025,
  author = {Phichaphop, Asa and Sorajja, Paul and Enriquez-Sarano, Maurice and Fukui, Miho and Okada, Atsushi and Margonato, Davide and Abed, Mohammed and Nishihara, Takahiro and Koike, Hideki and Walser-Kuntz, Evan and Lesser, John R and Cheng, Victor Y and Bapat, Vinayak N and Hamid, Nadira and Cavalcante, João L},
  title = {Feasibility of Computed Tomography as a Gatekeeper for Invasive Angiography Before TAVR: A Pragmatic Real-World Experience},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1161/circinterventions.125.015181}
}
Kostenlos starten →